title: Using Novel Agents and Stem Cell Transplantation to Optimally Manage Immunoglobulin Light Chain Amyloidosis.
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, Minnesota. Electronic address: gertz.morie@mayo.edu.
authors.forename: Morie A
authors.initials: MA
authors.lastname: Gertz
mesh_terms: D000686:Amyloidosis / Q000188:drug therapy* / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069286:Bortezomib / Q000627:therapeutic use*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D060828:Induction Chemotherapy / Q000379:methods*; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D000069286:Bortezomib; D008558:Melphalan